| Literature DB >> 29257840 |
Flávio Heuta Ivano1, Izabela Rodrigues Villela1, Lívia Fouani de Miranda1, Thaísa Sami Nakadomari1.
Abstract
BACKGROUND: The double balloon enteroscopy is an important method for the endoscopic approach of the small bowel that provides diagnosis and therapy of this segment's disorders, with low complication rate. AIM: Analysis of patients undergoing double balloon enteroscopy. The specific objectives were to establish the indications for this method, evaluate the findings by the double balloon enteroscopy, analyze the therapeutic options and the complications of the procedure.Entities:
Mesh:
Year: 2017 PMID: 29257840 PMCID: PMC5543783 DOI: 10.1590/0102-6720201700020002
Source DB: PubMed Journal: Arq Bras Cir Dig ISSN: 0102-6720
Frequency of indications of double balloon enteroscopy
| Indications | Frequency n (%) |
| Prior bariatric surgery | 3 (4,6%) |
| Prior intestinal surgery | 2 (3,1%) |
| Diarrhea | 1 (1,5%) |
| Crohn´s disease | 5 (7,7%) |
| Abdominal pain | 6 (9,2%) |
| Duodenal lymphoma | 1 (1,5%) |
| Intestinal oclusion | 1 (1,5%) |
| Gatrointestinal bleeding | 23 (35,4%) |
| Gardner´s Syndrome | 5 (7,7%) |
| Indeterminate | 18 (27,7%) |
| Total | 65 (100%) |
Frequency of findings of double balloon enteroscopy
| Findings | Frequency n (%) |
| Adenomas | 1 (1,5%) |
| Angioectasias | 7 (10,8%) |
| Angioectasia and pseudodivertículum | 1 (1,5%) |
| Divertículum | 2 (3,1%) |
| Duodenitis | 4 (6,2%) |
| Stenosis | 1 (1,5%) |
| Stenosis and atrofhy | 1 (1,5%) |
| Stenosis and pseudopolyp | 2 (3,1%) |
| Elevated formation | 1 (1,5%) |
| Gastritis | 1 (1,5%) |
| Ileitis | 2 (3,1%) |
| Ulcerated lesions | 3 (4,6%) |
| Melaena | 1 (1,5%) |
| Polyps | 9 (13,8%) |
| EDB without alterations | 29 (44,6%) |
| Total | 65 (100%) |
Findings of double balloon enteroscopy
| Findings | Frequency (n) |
| Adenoma in duodenal papilla and ulcerated lesion in the jejunojejunal anastomosis | 1 |
| Duodenal and proximal jejunum angioectasia | 1 |
| Duodenal and proximal jejunum angioectasia; elevated formation in the proximal jejunum | 1 |
| Proximal jejunum angioectasias | 1 |
| Scattered angioectasias in duodenum and distal jejunum l | 1 |
| Meckel´s diverticulum | 1 |
| Colon diverticula and venous ectasias in the right colon | 1 |
| Duodenitis and extensive angiectasia in afferent loop | 1 |
| Erosive duodenitis, erosions and ulcers in the proximal and medium jejunum | 1 |
| Erosive duodenitis, middle jejunum mucosal thickening and exsudative erosions on distal jejunum | 1 |
| Infiltrative duodenitis | 1 |
| Duodenal stenosis | 1 |
| Distal jejunum angioectasia | 1 |
| Elevated formation in the terminal ileum | 1 |
| Ulcerated subepithelial elevated formations in the proximal jejunum and xanthomatous lesions in the distal jejunum | 1 |
| Ulcerated subepithelial formations in duodenum and lymphoid hyperplasia in the duodenal bulb | 1 |
| Angiectasia formations in the proximal jejunum and lipoma in the jejunum | 1 |
| Angiectases formations in the distal duodenum | 1 |
| Discret enanthematous gastritis of the excluded stomach (after bariatric surgery) | 1 |
| Internal hemorrhoids grade 2 and angiectases at rectosigmoid; pseudo diverticula of the sigmoid | 1 |
| Internal hemorrhoids grade 2 and mild erosive ileitis | 1 |
| Exudative ileitis | 1 |
| Ulcerated infiltrative lesions in duodenal with stenosis | 1 |
| Melaena | 1 |
| Normal | 29 |
| Polyp in middle jejunum | 1 |
| Polyp in the duodenum, proximal jejunum and middle jejunum | 2 |
| Polyp in proximal jejunum and ileum | 1 |
| Sessile polyps in the proximal jejunum | 1 |
| Duodenal polyps | 1 |
| Polyps in the duodenum and proximal jejunum | 2 |
| Jejunal polyp | 1 |
| Substenosis in middle jejunum and stenosis in distal jejunum with sentinel pseudopolyp | 2 |
| Substenosis on medium jejunum and distal jejunum stenosis; atrophy of the jejunal mucosa | 1 |
| Total | 65 |
Frequency of performed therapy
| Therapeutics | Frequency n (%) |
| Biopsy and polypectomy | 3 (4,6%) |
| Biopsy | 12 (18,5%) |
| Biopsy and tatoo with spot | 1 (1,5%) |
| Sclerotherapy and APC | 1 (1,5%) |
| APC | 5 (7,7%) |
| APC and biopsy | 1 (1,5%) |
| EMR and polypectomy | 3 (4,6%) |
| EMR, APC and biopsy | 1 (1,5%) |
| Polipectomy | 4 (6,2%) |
| Tattoo with nankin spot | 1 (1,5%) |
| None | 33 (50.8%) |
| Total | 65 (100%) |
Relationship between the findings and therapy - Part 1
| Therapeutics | ||||||
| Findings | Biopsy and polypectomy n (%) | Biopsy n (%) | Biopsy and tattoo with nankin spot n (%) | Sclerotherapy and argon plasma fulguration n (%) | Argon plasma fulguration n (%) | Argon plasma fulguration and biopsy n (%) |
| Adenoma | 0 | 1 (100%) | 0 | 0 | 0 | 0 |
| Angioectasias | 0 | 0 | 0 | 0 | 5 (71,4%) | 1 (14,3%) |
| Angioectasias and pseudodiverticula | 0 | 0 | 0 | 0 | 0 | 0 |
| Diverticula | 0 | 0 | 1 (50%) | 0 | 0 | 0 |
| Duodenitis | 0 | 3 (75%) | 0 | 1 (25%) | 0 | 0 |
| Stenosis | 0 | 1 (100%) | 0 | 0 | 0 | 0 |
| Stenosis and atrophy | 0 | 1 (100%) | 0 | 0 | 0 | 0 |
| Stenosis and pseudopolyp | 2 (100%) | 0 | 0 | 0 | 0 | 0 |
| Elevated formation | 0 | 1 (100%) | 0 | 0 | 0 | 0 |
| Gastritis | 0 | 1 (100%) | 0 | 0 | 0 | 0 |
| Ileitis | 0 | 2 (100%) | 0 | 0 | 0 | 0 |
| Ulcerated lesions | 0 | 1 (33,3%) | 0 | 0 | 0 | 0 |
| Melaena | 0 | 0 | 0 | 0 | 0 | 0 |
| Polyps | 1 (11,1%) | 0 | 0 | 0 | 0 | 0 |
| DBE without alterations | 0 | 1 (3,4%) | 0 | 0 | 0 | 0 |
| Total | 3 (4,6%) | 12 (18,5%) | 1 (1,5%) | 1 (1,5%) | 5 (7,7%) | 1 (1,5%) |
Relationship between the findings and therapy - Part 2
| Therapeutics | |||||
| Findings | Mucosectomy and polypectomy n (%) | Mucosectomy, argon plasma fulguration and biopsy n (%) | Polypectomy n (%) | Tattoo with spot n (%) | None n (%) |
| Adenoma | 0 | 0 | 0 | 0 | 0 |
| Angioectasias | 0 | 0 | 0 | 0 | 1 |
| Angioectasias and pseudodiverticula | 0 | 0 | 0 | 0 | 1 (100%) |
| Diverticula | 0 | 0 | 0 | 0 | 1 (50%) |
| Duodenitis | 0 | 0 | 0 | 0 | 0 |
| Stenosis | 0 | 0 | 0 | 0 | 0 |
| Stenosis and atrophy | 0 | 0 | 0 | 0 | 0 |
| Stenosis and pseudopolyp | 0 | 0 | 0 | 0 | 0 |
| Elevated formation | 0 | 0 | 0 | 0 | 0 |
| Gastritis | 0 | 0 | 0 | 0 | 0 |
| Ileitis | 0 | 0 | 0 | 0 | 0 |
| Ulcerated lesions | 0 | 0 | 0 | 1 (33%) | 1 (33%) |
| Melaena | 0 | 0 | 0 | 0 | 1 (100%) |
| Polyps | 3 (33,3%) | 1 (11,1%) | 4 (44,4%) | 0 | 0 |
| DBE without alterations | 0 | 0 | 0 | 0 | 28 (96,6%) |
| Total | 3 (4,6%) | 1 (1,5%) | 4 (6,2%) | 1 (1,5%) | 22 (50,8%) |
| Melaena | 0 | 0 | 0 | 0 | 1 (100%) |
| Polyps | 3 (33,3%) | 1 (11,1%) | 4 (44,4%) | 0 | 0 |
| DBE without alterations | 0 | 0 | 0 | 0 | 28 (96,6%) |
| Total | 3 (4,6%) | 1 (1,5%) | 4 (6,2%) | 1 (1,5%) | 22 (50,8%) |